Live better longer.

Working to create a world where everyone can have
healthy minds and healthy bodies at every age.

Learn More

A mission-driven community
of investigators

The Buck is a collective of the world’s top scientists in the field of aging who are sharing their methods and
expertise to find ways to help everyone lead fuller, healthier lives by ending age-related disease.

Learn More

Advancing the frontiers
of research on aging

Using cutting-edge science to tackle aging, the #1 risk factor for chronic disease.

Learn More

Our mission is to end the threat of age-related disease for this and future generations

We believe it is possible for people to enjoy their lives at 95 as much as they do at 25, and to achieve that, we’re seeking a more comprehensive understanding of the biology of aging itself.

Advancing the frontiers
of aging research

Using cutting-edge science to tackle aging, the #1 risk factor for chronic disease.

World’s first Center for Female Reproductive Longevity and Equality established at the Buck Institute for Research on Aging

A $6 million gift provides seed money to address a long-standing inequality: men can reproduce throughout their lifespan; but women's fertility begins to decline in their early 30's...

Judy Campisi elected to the National Academy of Sciences for her pioneering work on cellular senescence

How does great science happen, and how does a great scientist get her start? The answers might surprise you.

A Potential New Therapeutic Approach for Parkinson’s Disease

“What I want people to know about the Buck is the incredible commitment and excitement that permeates the walls of this institution. We are pushing the frontiers in an area that is going to impact all of humanity. I cannot tell you exactly when this will happen, but I can tell you big discoveries will come out of the Buck.”

Eric Verdin, MD, Buck Institute President and CEO

First patient treated with drug based on Buck research

June 25, 2018: Unity Biotechnology, which incubated at the Buck Institute, has treated the first patient in a Phase I clinical trial evaluating a drug to selectively eliminate senescent cells in moderate to severe osteoarthritis of the knee...

Geriatrician-scientist John Newman, MD, PhD, joins the Buck faculty

Geriatrician and researcher in the field of aging poised to bridge gap between lab and clinical practice.

Largest “pan-cancer” genomics study spurs future efforts to enroll patients in specialized “basket” clinical trials

Buck professor Chris Benz is senior co-author of several papers publishing in Cell based on the Cancer Genome Atlas project.
View more news

Here’s what’s happening

Upcoming events that feature Buck science


Formal research seminars

Click “read more” for full schedule

Inflammation & Aging: The Levy Community Seminar & Member Event

A conversation with Buck professor Judy Campisi

North Bay Science Discovery Day

100 hands-on experiences for kids and kids at heart!

Bay Area Aging Meeting (BAAM)

Industry event

Anti-ageing gets another boost with Napa Therapeutics launch via @pmlivecom

If dunking Buck’s CEO @EricVerdin is wrong, I don’t want to be right!#BuckSummerParty2018 #Livebetterlonger

Front page story highlights the Buck’s new Center for Female Reproductive Longevity and Equality #livebetterlonger

$6 million gift to focus @BuckInstitute on 'ovarian aging,' fertility

Thrilled to announce the establishment of the world’s first Center for Female Reproductive Equality and Longevity. #Livebetterlonger

Visit the
Buck Institute

Come and share in the excitement. Our doors are open, and we love talking about our science.

Join the fight against age-related diseases

You don’t have to be a scientist to make an important contribution to research on aging. We rely on donations to support the science that we believe will add years to people’s lifespan and decades to their healthspan.

Learn more